NEXENTIS TECHNOLOGIES INC. Payments to Acquire Investments
NEXENTIS TECHNOLOGIES INC. (NXTS) reported Payments to Acquire Investments of $203.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireInvestments · last filed 2024-11-14
- NEXENTIS TECHNOLOGIES INC. payments to acquire investments for the quarter ending 2024-09-30 was $41.00K, a 90.19% decline year-over-year.
- NEXENTIS TECHNOLOGIES INC. payments to acquire investments for the quarter ending 2023-12-31 was $1.00.
- NEXENTIS TECHNOLOGIES INC. payments to acquire investments for the quarter ending 2023-09-30 was $417.89K.
- NEXENTIS TECHNOLOGIES INC. payments to acquire investments for fiscal 2023 was $1.54M.
| Period end | Payments to Acquire Investments 3 month | Payments to Acquire Investments 6 month | Payments to Acquire Investments 9 month | Payments to Acquire Investments 12 month |
|---|---|---|---|---|
| 2024-09-30 | $41.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $203.00K 10-Q · filed 2024-11-14 | ||
| 2024-06-30 | $162.00K 10-Q · filed 2024-08-14 | |||
| 2023-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $417.89K derived: sum of 2 quarters · filed 2024-11-14 | $1.54M 10-K · filed 2024-04-01 | |
| 2023-09-30 | $417.89K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | $1.54M 10-Q · filed 2024-11-14 | ||
| 2023-06-30 | $1.12M 10-Q · filed 2024-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |